Changes in Retinal Thickness and Brain Volume during 6.8-Year Escalating Therapy for Multiple Sclerosis

Table 1

Demographic and clinical characteristics.

Female/male (ratio)	14/4 (3.5)
Age, years
MS duration, years
Follow-up duration, years	6.8 (4.2-8.3)
Untreated/treated,	12/6
OB positive in CSF	17/17 (100)
OB count in CSF	10 (2–10)
History of ON	6 (33.3)
CSF cell count, ×10^6/L	6.1 (0.5–11.6)
Pleocytosis in CSF,	10/17 (58.8)

Abbreviations: OB: oligoclonal bands; DMT: disease-modifying treatment; OCT: optical coherence tomography; ON: opticus neuritis; CSF: cerebrospinal fluid. If not specified, values are (%), , or median (interquartile range).